Author's reply: the influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy

Source: Clinical Endocrinology, Volume 67, Number 1, July 2007 , pp. 159-159(1)

Publisher: Wiley-Blackwell

Document Type: Letter to the Editor

DOI: http://dx.doi.org/10.1111/j.1365-2265.2007.02839.x

Publication date: 2007-07-01

• In this: publication
• By this: publisher
• In this Subject: Anatomy & Physiology ,  Internal Medicine

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers